CRSP has been in the news 900% more than usual
May 01, 2025, 4:32 AM
-4.87%
What does CRSP do
CRISPR Therapeutics AG, headquartered in Zug, develops gene-based medicines for serious diseases using its CRISPR/Cas9 platform and went public on October 19, 2016. The company focuses on gene editing to treat genetically-defined diseases and enhance cellular therapies.
CRSP has been in the news recently: Kytopen and Aldevron are working together to improve cell therapy manufacturing by integrating their technologies for better CRISPR-mediated T-cell engineering and increased yields. This collaboration is relevant to CRISPR Therapeutics AG, as it enhances the potential applications of CRISPR technology in therapeutic developments.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.